Maravai LifeSciences
MRVI
MRVI
210 hedge funds and large institutions have $1.18B invested in Maravai LifeSciences in 2024 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 74 increasing their positions, 72 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 223 → 210 (-13)
26% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 47
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
210
Holding in Top 10
2
Calls
$3.48M
Puts
$1.81M
Top Buyers
| 1 | +$18.9M | |
| 2 | +$18.9M | |
| 3 | +$13.9M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$7.61M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$7.13M |
Top Sellers
| 1 | -$27.2M | |
| 2 | -$19.4M | |
| 3 | -$17.9M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$10.4M |
| 5 |
EIP
Epoch Investment Partners
New York
|
-$9.56M |